These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2996408)

  • 1. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.
    Petricciani JC
    Ann Intern Med; 1985 Nov; 103(5):726-9. PubMed ID: 2996408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs.
    JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-III testing of donor blood imminent; complex issues remain.
    Goldsmith MF
    JAMA; 1985 Jan; 253(2):173-5, 179-81. PubMed ID: 2981368
    [No Abstract]   [Full Text] [Related]  

  • 5. Decision analysis of the HTLV-III screening test for blood donors.
    Ellwein LB; Purtilo DT; Purtilo RB
    AIDS Res; 1986 Feb; 2(1):5-17. PubMed ID: 3013219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.
    Fang CT; Darr F; Kleinman S; Wehling RH; Dodd RY
    Transfusion; 1986; 26(2):208-9. PubMed ID: 3006302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood.
    Barrett JE; Dawson G; Heller J; Bairstow C; Fico R; Webber JS; Gutierrez R; Decker RH
    Am J Clin Pathol; 1986 Aug; 86(2):180-5. PubMed ID: 3017089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
    Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
    Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of human T-lymphotropic virus type III test kits reported from blood collection centers--United States, April 22,-May 19, 1985.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):375-6. PubMed ID: 2989678
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products.
    Erfle V; Hehlmann R; Mellert W; Goebel FD; Rasokat H; Lechler E; Hellstern P; Köhler M; Seifried E; Heimpel H
    Blut; 1985 Oct; 51(4):243-9. PubMed ID: 2996664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leads from the MMWR. Results of human T-lymphotropic virus type III test kits reported from blood collection centers--United States, April 22 to May 19, 1985.
    JAMA; 1985 Aug; 254(6):741. PubMed ID: 2989567
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.